MedTrace Logo

Increasing Attendance to Cervical Cancer-screening Among Immigrants

NCT03155581 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 230

Last updated 2018-12-19

No results posted yet for this study

Summary

Although health-related interventions should become increasingly diversity-sensitive, there will always be a need of adapting specific interventions to some immigrant populations. Adapting selected services to the individual cultural and religious background is necessary to reduce health inequalities and provide effective health care and is dependent on the active involvement of users. In this proposal the investigators present a community-based health intervention trial with two parallel interventions aimed at increasing participation of immigrant women to the existing cervical cancer-screening program. Through this study, the investigators will provide new practice-based knowledge and a firmer evidence base to improve health interventions that can contribute to equal health care and good health for all - including the immigrant population.

Based on identified barriers and factors that influence the interactions between immigrants and health care professionals for screening of cervical cancer in Norway, the investigators have develop two adapted interventions. One strategy will target immigrant women, and the other one will focus on general practitioners. Thus, this proposal will specifically contribute to the development of personalized health prevention interventions for the most common cancer-screening program in Norway, with a focus on immigrant's personal circumstances and health care needs.

Conditions

Interventions

BEHAVIORAL

User intervention

To make participants aware of the lack of participation in screening programs and its consequences, and help to manage obstacles to participation

BEHAVIORAL

Health professional intervention

To provide information on the low attendance of migrants to cervical cancer screening and tools to improve the situation

Sponsors & Collaborators

  • The Norwegian Centre for Minority Health Research

    collaborator OTHER

  • University of Bergen

    lead OTHER

Principal Investigators

  • Esperanza Diaz, MD, PhD · University of Bergen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-01
Primary Completion
2018-06-30
Completion
2018-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03155581 on ClinicalTrials.gov